Literature DB >> 21470090

Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia.

Michael Richards1, James Knox, Briony Elliott, Kate Mackin, Dena Lyras, Lynette J Waring, Thomas V Riley.   

Abstract

We report the first recognised case of infection with Clostridium difficile PCR ribotype 027 acquired in Australia. This pathogen has caused significant morbidity and mortality in widespread hospital-based outbreaks in the northern hemisphere. Clinicians need to be aware of the clinical picture, limitations of diagnostic tests, availability of further testing for epidemic strains, new therapeutic approaches, and in-hospital control strategies for this infection. ©The Medical Journal of Australia 2011

Entities:  

Mesh：

Year:  2011        PMID： 21470090     DOI： 10.5694/j.1326-5377.2011.tb03012.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


  16 in total

1.  Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.

Authors:  Jen Kok; Qinning Wang; Lee C Thomas; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

2.  Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies.

Authors:  J Hart; P Putsathit; D R Knight; L Sammels; T V Riley; A Keil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-30       Impact factor: 3.267

3.  Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Authors:  Luis Furuya-Kanamori; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Stacey Hong; Tiffany Harris-Brown; Jenny Robson; Archie C A Clements
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

Review 4.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

5.  Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.

Authors:  Kristin J Nagaro; S Tyler Phillips; Adam K Cheknis; Susan P Sambol; Walter E Zukowski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

6.  Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018.

Authors:  Stacey Hong; Papanin Putsathit; Narelle George; Christine Hemphill; Peter G Huntington; Tony M Korman; Despina Kotsanas; Monica Lahra; Rodney McDougall; Casey V Moore; Graeme R Nimmo; Louise Prendergast; Jennifer Robson; Lynette Waring; Michael C Wehrhahn; Gerhard F Weldhagen; Richard M Wilson; Thomas V Riley; Daniel R Knight
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

7.  The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.

Authors:  Glen P Carter; Gillian R Douce; Revathi Govind; Pauline M Howarth; Kate E Mackin; Janice Spencer; Anthony M Buckley; Ana Antunes; Despina Kotsanas; Grant A Jenkin; Bruno Dupuy; Julian I Rood; Dena Lyras
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

8.  Emergence and global spread of epidemic healthcare-associated Clostridium difficile.

Authors:  Miao He; Fabio Miyajima; Paul Roberts; Louise Ellison; Derek J Pickard; Melissa J Martin; Thomas R Connor; Simon R Harris; Derek Fairley; Kathleen B Bamford; Stephanie D'Arc; Jon Brazier; Derek Brown; John E Coia; Gill Douce; Dale Gerding; Hee Jung Kim; Tse Hsien Koh; Haru Kato; Mitsutoshi Senoh; Tom Louie; Stephen Michell; Emma Butt; Sharon J Peacock; Nick M Brown; Tom Riley; Glen Songer; Mark Wilcox; Munir Pirmohamed; Ed Kuijper; Peter Hawkey; Brendan W Wren; Gordon Dougan; Julian Parkhill; Trevor D Lawley
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

9.  Prevalence of Clostridium difficile colonization among healthcare workers.

Authors:  N Deborah Friedman; James Pollard; Douglas Stupart; Daniel R Knight; Masoomeh Khajehnoori; Elise K Davey; Louise Parry; Thomas V Riley
Journal:  BMC Infect Dis       Date:  2013-10-04       Impact factor: 3.090

10.  Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.

Authors:  Grace S Crowther; Caroline H Chilton; Sharie L Todhunter; Scott Nicholson; Jane Freeman; Simon D Baines; Mark H Wilcox
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.